Suchergebnisse - "Jia, Yijun"

PubPharm (50)

1

Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer

enthalten in: BMC medicine | 2024

von Han, R. | Guo, H. | Shi, J. | +8

2

Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer

enthalten in: BMC medicine | 2024

von Han, R. | Guo, H. | Shi, J. | +8

3

Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics

enthalten in: BMC medical genomics | 2024

von Cao, B. | Sun, C. | Bi, R. | +7

4

Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics

enthalten in: BMC medical genomics | 2024

von Cao, B. | Sun, C. | Bi, R. | +7

5

Donor-derived cell-free DNA as a diagnostic marker for kidney-allograft rejection : A systematic review and meta-analysis

enthalten in: Biomolecules & biomedicine | 2024

von Xing, Y. | Guo, Q. | Wang, C. | +5

6

Tumour microenvironment changes after osimertinib treatment resistance in non-small cell lung cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Han, R. | Guo, H. | Shi, J. | +9

7

Assistant decision-making method and system for injury control resuscitation

enthalten in: Europäisches Patentamt | 2023

von ZONG ZHAOWEN | YANG HAOYANG | DU WENQIONG | +9

8

Characterization of Combined Blast- and Fragment-Induced Pelvic Injuries and Hemostatic Resuscitation in Rabbits

enthalten in: The Journal of surgical research | 2023

von Ye, Z. | Zong, Z. | Zhong, X. | +5

9

Features of Coagulo-Fibrinolytic Derangement Due to Bleeding in Nonacclimatized Rabbits Acutely Exposed to High Altitude

enthalten in: High altitude medicine & biology | 2023

von Zhong, X. | Du, W. | Zong, Z. | +4

10

Interleukin-10 induces expression of CD39 on CD8+T cells to potentiate anti-PD1 efficacy in EGFR-mutated non-small cell lung cancer

enthalten in: Journal for immunotherapy of cancer | 2022

von Qiao, M. | Zhou, F. | Liu, X. | +10

1
2
3
4
5
Nächster »
[5]